National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 10 of 1989)

This Act has been repealed and is no longer in force. It is retained for historical reference.

This declaration removes five specific medications from the Pharmaceutical Benefits Scheme (PBS) — the government program that subsidizes prescription medicines for Australians.

What changes: From 1 December 1989, the following drugs ceased to be subsidized by the government:

Biphasic Insulin (used for diabetes)
Insulin Zinc Suspension (Amorphous) (used for diabetes)
Vasopressin Tannate (used for diabetes insipidus and bleeding disorders)
Crystal Violet B.P. 1980 (an antiseptic dye)
Testosterone B.P. (hormone replacement therapy)

Who made this: Jeffrey Allan Harmer, acting as a delegate (authorized representative) of the Minister for Community Services and Health, used powers under section 85(2AA) of the National Health Act 1953 to make this change.

Why it matters: When a drug is removed from the PBS, patients must pay the full private price rather than the subsidized government co-payment. This instrument represents a routine administrative delisting.

COMMONWEALTH OF AUSTRALIA

NATIONAL HEALTH ACT 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUB-SECTION 85(2AA)

No. PB10 of 1989

I, JEFFREY ALLAN HARMER, Acting Principal Advisor, Health Care Access Division, Department of Community Services and Health and Delegate of the Minister of State for Community Services and Health, pursuant to sub-section 85(2AA) of the National Health Act 1953, hereby make the following Declaration:

This Declaration shall come into operation on 1 December 1989.
The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Insulin, Biphasic

Insulin Zinc Suspension (Amorphous)

Vasopressin Tannate

Crystal Violet B.P. 1980

Testosterone B.P.

Dated this seventeenth day of November 1989.

J.A. HARMER

ACTING PRINCIPAL ADVISOR

HEALTH CARE ACCESS DIVISION

DELEGATE OF THE MINISTER OF STATE FOR COMMUNITY SERVICES AND HEALTH

1 National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 10 of 1989)

COMMONWEALTH OF AUSTRALIA

NATIONAL HEALTH ACT 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUB-SECTION 85(2AA)

No. PB10 of 1989

This Declaration shall come into operation on 1 December 1989.
The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Insulin, Biphasic

Insulin Zinc Suspension (Amorphous)

Vasopressin Tannate

Crystal Violet B.P. 1980

Testosterone B.P.

Dated this seventeenth day of November 1989.

J.A. HARMER

ACTING PRINCIPAL ADVISOR

HEALTH CARE ACCESS DIVISION

DELEGATE OF THE MINISTER OF STATE FOR COMMUNITY SERVICES AND HEALTH

National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 10 of 1989)

Plain English Summary

Deep dive

Current sections

National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 10 of 1989)

Source text

1 National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 10 of 1989)